Sepsis is a medical emergency demanding early diagnosis and tailored antimicrobial therapy. Every hour of delay in initiating effective therapy measurably increases patient mortality. Blood culture is currently the reference standard for detecting bloodstream infection, a multistep process which may take one to several days. Here, we report a novel paradigm for earlier detection and the simultaneous identification of pathogens in spiked blood cultures by means of a metabolomic "fingerprint" of the volatile mixture outgassed by the organisms. The colorimetric sensor array provided significantly faster detection of positive blood cultures than a conventional blood culture system (12.1 h versus 14.9 h, P < 0.001) while allowing for the identification of 18 bacterial species with 91.9% overall accuracy within 2 h of growth detection. The colorimetric sensor array also allowed for discrimination between unrelated strains of methicillin-resistant Staphylococcus aureus, indicating that the metabolomic fingerprint has the potential to track nosocomial transmissions. Altogether, the colorimetric sensor array is a promising tool that offers a new paradigm for diagnosing bloodstream infections.
B
loodstream infection (BSI) due to bacteria and fungi is a medical emergency demanding early diagnosis and tailored antimicrobial therapy (1) . Every hour of delay in the diagnosis of sepsis increases patient mortality (2) . A definitive diagnosis of BSI is achieved through the recovery of the organisms from blood (3) . Currently, clinical laboratories employ a two-step strategy: the first step involves the use of an automated blood culture system to detect the presence of growing organisms in blood culture. This is achieved through sensing a change in the pH or headspace pressure. In the second step, positive cultures are processed for species identification using phenotypic and genotypic assays. Phenotypic methods include a coagulase tube test for staphylococci, biochemical arrays in automated identification systems, and most recently, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (4, 5) . Genotypic identification methods include fluorescence in situ hybridization (FISH) with peptide nucleic acid (PNA) probes for a limited number of species and several commercially available multiplex nucleic acid amplification tests (NAATs) for a broad range of species recovered from blood cultures (3, (5) (6) (7) (8) . With the existing blood culture systems, the time to positive result typically ranges from 1 to 3 days, and an additional 1 to 2 days is needed for species identification with conventional methods, although MALDI-TOF MS and genotypic methods have shortened this time to hours instead of days. Meanwhile, patients are treated empirically with broad-spectrum antibiotics until the etiologic agent is identified and its susceptibility to antibiotics is determined (3) . This approach puts the patient at risk for ineffective antimicrobial therapy and selection for antibiotic-resistant organisms.
Other assays used to speed up the diagnosis of BSI include NAATs for organisms and enzyme immunoassays for inflammatory biomarkers in whole blood and serum, respectively (3). However, NAATs do not have sufficient sensitivity and specificity to replace microbial cultures (9) , while biomarkers are nonspecific and unable to identify the etiology (10, 11) . Thus, novel approaches are needed to reduce time to diagnosis of BSI.
The colorimetric sensor array (CSA) is an artificial olfaction technology used for rapid and accurate discrimination of complex mixtures or volatile organic compounds (VOCs) (12, 13) . The CSA consists of a high-dimensional array of diverse chemically responsive indicators embedded in a nanoporous matrix. Each indicator has distinct chemical reactivity with volatiles and changes different colors upon exposure to VOCs at concentrations as low as parts-per-billion. The resulting pattern of color changes comprises a high-dimensional signature that is unique for each volatile mixture. Moreover, the CSA includes rapidly reversible indicators that allow the sensor to track temporal fluctuations in headspace VOCs. When placed in bacterial cultures growing on agar, the CSA can distinguish between bacterial species with 98.8% accuracy (14) . In this report, we describe the application of the CSA for early detection and the simultaneous identification of blood cultures inoculated with sepsis-causing bacteria. We also describe the potential application of the CSA for discriminating different strains of methicillin-resistant Staphylococcus aureus (MRSA).
MATERIALS AND METHODS
Blood culture preparation. Bacterial species and strains were obtained from the Stanford University Medical Center clinical microbiology laboratory strain collection. Eighteen species of bacteria commonly recovered from blood cultures (15) were selected for building species-specific CSA signatures (see Table S1 in the supplemental material). Each species was represented by one type strain from the American Type Culture Collection (ATCC) and two clinical strains, except for S. aureus, which had 11 clinical strains, and for Enterobacter cloacae, which had only one clinical strain. For inoculum preparation, colonies from sheep blood agar (Difco) were suspended in sterile saline, and the turbidity was adjusted to a 0.5 McFarland standard. Each suspension was then serially diluted and plated to confirm the concentration. A bacterial suspension of 0.5 ml from the appropriate dilution (see below) was injected into a BacT/Alert standard aerobic bottle (bioMérieux, Inc.), along with 10 ml of whole blood purchased from Stanford University Blood Center. For initial experiments, the content of blood culture bottles was aseptically transferred to a petri dish. For subsequent experiments, the inoculated bottle was tested using either the BacT/Alert system or the CSA system. For the CSA system, the bottle septum was replaced with the CSA adaptor prior to incubation (Fig.  1) . The inoculum concentration was 10 CFU/ml in blood culture bottle trials and ranged from 2.5 to 1,000 CFU/ml of blood in the petri dish trials. Blood culture bottles inoculated with blood without organisms were included as negative controls. Upon the completion of each trial, the blood culture medium was plated onto sheep blood agar to confirm purity. The detailed list of all trials, including the technical and biological repetitions, is shown in Table S1 in the supplemental material.
CSA blood culture prototype instrument. The CSA system has two major components: a disposable sensor and an optical scanner (Fig. 1) . The manufacturing procedures of the CSA have been described previously (12, 16) . A cap was custom designed to fit bioMérieux's standard aerobic bottle due to availability of the BacT/Alert 3D automated blood culture system in our laboratory. The sensor array was mounted inside the transparent cap or placed on a petri dish cover with a sufficient air gap to ensure adequate diffusion of the headspace gases.
Detection time. The CSA was imaged every 20 min after inoculation using a flatbed scanner. For each image, red, green, and blue (RGB) color values were extracted to create a time series of color changes. Using this time series, bacterial growth was detected by one of three trigger indicators in the sensor array. To identify each trigger indicator, the time series for each trial in the targeted species was reduced to the minimum and maximum slopes of the RGB color changes for each indicator during that trial. Each feature was ranked using Welch's two-tailed t test with false-discovery-rate correction, and a logistic regression analysis was used to fit a detection threshold for the feature with the lowest corrected P value. The detection time was defined as the earliest time that any of the three trigger indicator slopes crossed its detection threshold.
Species classifier. To create a CSA signature for each species, the slopes of the RGB color changes were sampled for each indicator at 1-h intervals, starting 3 h before the detection time and up to 9 h after detection. A species classifier was constructed by training a support vector machine (SVM) on the time series of color changes using the C-support vector classification (C-SVC) implementation in LibSVM (17) . Ten repetitions of 10-fold stratified cross-validation were used to evaluate classifier performance on a test set that did not include the training set used to build the classifier. One-versus-all classification performance for individual classes was constructed using sensitivity, specificity, and predictive values (18) . Feature selection and classification were performed in R using the stats and e1071 packages as well as the data mining framework RapidMiner (19) . Exact binomial confidence intervals were computed with the binom package (20) .
Strain typing. Pulsed-field gel electrophoresis (PFGE) genotyping was performed as previously described (21) . The PFGE dendrogram was generated by BioNumerics (22) . The similarity between the patterns was calculated using the Dice coefficient with settings at 1.25% optimization, 1.25% tolerance, and a "change toward the end of the fingerprint" value of 0.5%. The cluster analysis was done using the unweighted pair group method with arithmetic averages. CSA strain typing was performed by inoculating 9 different strains of MRSA at 10 CFU/ml in our standard blood culture bottle and collecting the sensor responses. For the CSA analysis, principal component analysis was performed, and the resulting 10 most important principal components were used for hierarchical cluster analysis using the minimum variance method.
RESULTS
Species-specific CSA signatures in blood culture. To establish that the CSA can detect species-specific VOC signatures in blood culture, we inoculated petri dishes with the BacT/Alert aerobic blood culture medium, human whole blood, and various concentrations (2.5 to 1,000 CFU/ml) of S. aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa and monitored the CSA response over time. After an initial equilibration to the VOCs released by the growth medium itself, bacterial growth triggered a species-specific pattern of color changes. The CSA kinetic profile showed a highly dynamic pattern, which is reflective of the changes in the headspace VOC composition over time (Fig. 2) . Using the kinetic profiles, the CSA was able to discriminate the four bacterial species with 96.8% accuracy (95% confidence interval [CI], 87.6 to 100%; see Table S2 in the supplemental material). The detection times at lower bacterial concentrations lagged behind the detection times at higher bacterial concentrations. However, the species-specific responses of key colorimetric indicators were independent of inoculum concentration.
Library construction of bacterial CSA signatures. Encouraged by the result in the petri dishes, we constructed a library of CSA signatures for 18 bacterial species in the BacT/Alert blood culture bottles using the CSA blood culture prototype instrument (Fig. 1) . In total, we assembled a data set of 1,192 blood culture trials. Out of 73 different indicators in the sensor array, 53 had a very strong response to bacterial volatiles. Most indicators responded with dynamic patterns, while a few indicators, such as Nile red, showed no response to any bacteria. Furthermore, one indicator, 5,10,15,20-tetrakis(4-methoxyphenyl)-21H,23H-porphine cobalt(II), was particularly important, as it consistently detected Acinetobacter baumannii, which generally had a weaker response than most other bacteria. A heat map used to visualize the average rates of color change with the CSA revealed unique signatures for the 18 species (Fig. 3 ). An accompanying dendrogram revealed the relationship between 18 bacterial species based on their VOC signatures (Fig. 3) (23) .
Detection time and identification accuracy. The CSA detected the presence of bacteria in the blood culture bottles (10 CFU/ml of blood) with 99.9% sensitivity. Most bacteria were detected within 13 h, but some species, such as Staphylococcus epidermidis and Staphylococcus lugdunensis, required longer incubation periods. Furthermore, certain species, such as Enterococcus faecium, had a larger standard deviation for detection time due to strain variability (strain ATCC 27270, 10.4 h Ϯ 0.3 h; strain IS-09, 20.1 h Ϯ 0.6 h; strain IS-23, 12.61 h Ϯ 0.6 h) and had an average detection time of 14.2 h with a standard deviation of Ϯ4.3 h. Overall, the CSA provided significantly faster detection with the blood cultures when directly compared to the bioMérieux BacT/ Alert system (12.1 h versus 14.9 h; P Ͻ 0.001) (Fig. 4) .
To evaluate the accuracy of the CSA for species identification, the sensitivity and specificity of the CSA were determined for each of the 18 species at the time of culture positivity and each subsequent hour, for a total of 9 h (Fig. 5) . Several species, such as P. aeruginosa, S. lugdunensis, and A. baumannii, were identified with Ͼ90% sensitivity at the time of blood culture detection, while other species had moderate sensitivities with an overall sensitivity of 82.5%. However, within 2 h after culture detection, sensitivity on average reached 91.9% (95% CI, 90.2 to 93.4%). With each additional hour, the identification sensitivity improved, and after 9 h, it reached an overall sensitivity and specificity of 95.3% (95% CI, 94.0 to 96.5%) and 99.7% (95% CI, 99.7 to 99.8%), respectively ( Fig. 5 ; see also Tables S3 and S4 in the supplemental material).
Reproducibility of CSA signature. Certain experimental parameters were not uniformly distributed for each species in our indicators was created using RGB-color-change slopes at 6 h after the detection time. Each feature was standardized to have zero mean and unit variance across all trials and was assigned a column in the heat map. A cluster dendrogram to the left of the heat map displays the relationships between the patterns. data sets, including blood source (due to donor variability), blood storage type (fresh versus banked), inoculum concentration (for petri dish trials only), and sensor manufacturing lot. To check that the high classification accuracy of the CSA was not due to spurious correlations with these potential confounders, we constructed principal component plots of E. coli and S. aureus and confirmed that varied blood source, inoculum concentrations, and array manufacturing lots did not affect the ability of the CSA to separate species (see Fig. S1 in the supplemental material).
Strain classification. We investigated the ability of the CSA to discriminate between individual strains within a species. We used pulsed-field gel electrophoresis (PFGE) genotyping as a reference standard to classify the degree of genetic relatedness for 9 clinical strains of MRSA comprising 3 genotypes (Fig. 6) . Remarkably, the two unrelated strains (genotypes B and C) separated completely from the cluster of seven related strains in a principal component space and hierarchical cluster analysis dendrogram, while the genetically related strains (genotypes A and A 1 ) overlapped substantially, indicating that the metabolomic fingerprint can discriminate between bacterial strains. However, further studies with more strains and species must be done to validate these preliminary results.
DISCUSSION
We have demonstrated that the CSA system simultaneously detects and identifies bacterial species significantly faster than existing standard methods that only detect the presence or absence of positive culture. We report the classification of all 18 clinically relevant species with 91.9% overall accuracy within 2 h of detection, which is approximately 1 h before the BacT/ Alert system reports the mere presence of bacteria. The CSA system combines incubation, detection, and identification into a single step, thus both speeding the time to positivity and furnishing a highly accurate system for species determination. The CSA also provides strain-specific data which may assist hospital epidemiologists in the identification and disruption of nosocomial outbreaks in real-time, which is not presently possible 
FIG 5
Sensitivity of CSA for species identification as a function of time following culture detection. At each hour after blood cultures were detected by CSA, the sensitivity of CSA for culture identification was calculated. The color map is based on sensitivity value, in which red and green represent minimum (49.7%) and maximum (Ͼ93%) sensitivities, respectively. (24) . The CSA method is intrinsically simple, safe, robustly repeatable, and inexpensive, and thus offers an alternative platform for the characterization of blood cultures, particularly in resourcepoor settings, where technical expertise is limited. Most importantly, the CSA facilitates earlier treatment with species-specific antibiotics, leading to reduced utilization of unnecessary antibiotics and improved outcome in patients receiving tailored antibiotic regimens.
In recent years, MALDI-TOF MS has been developed for rapid and accurate identification of pathogens in blood cultures (25) . Although MALDI-TOF MS reduces the time to identification when performed on blood cultures, it is not performed until a positive blood culture signal has been obtained, and therefore it registers a result hours after the methods reported here. It also requires blood culture handling and processing, which takes time, incurs labor costs, raises the possibility of human error in sample preparation, and can pose a biohazard risk to the operator. At present, successful identification rates for MALDI-TOF MS are good for Gram-negative species, for which adequate CFU/ml are present, but for Grampositive species or comparatively dilute positive cultures, only 67% to 80% reached acceptable confidence score results (4) . Most recently, on-demand multiplex NAATs have been developed and commercialized for the identification of up to 92% of positive blood cultures (3, 6) . However, these tests also require minor sample handling and processing of 1 to 4 h, which adds additional time to the laboratory diagnosis of BSI.
Sources of error that must be assessed as this system is developed for clinical use include the potential misclassification of samples that contain bacterial species novel to the library, as well as mixed cultures and phenotypically distinct species that have very similar VOC patterns. The database in this study consisted of 1,192 entries of bacterial signatures derived from 18 different species, with an average of three different strains per species, and we believe that the system will become increasingly accurate with the inclusion of more strains per species to account for the diversity that exists between strains in the population at large. Other diagnostic databases, such as MALDI-TOF MS, address this issue by including at least 15 to 20 different isolates of one species to create a reference spectrum for each species (26) . It is likely that the clinical introduction of the CSA system will require the generation of a pattern library built up with a similarly broad range of strains for each species classified. Prior studies indicated that the bacterial concentrations in the blood of adult patients with BSI typically range from 1 to 30 CFU/ml (27) (28) (29) . In this study, blood culture bottles were spiked with bacterial species at a clinically relevant inoculum concentration of 10 CFU/ml of blood. As demonstrated with four species, the classification ability of the CSA is fairly robust with respect to variations in inoculum concentrations. Some patients, however, may have Ͻ1 CFU/ml (30) , which is outside the boundary of the conditions evaluated here; future assessment is needed to assess the ability of the CSA to classify pathogens in lower bacterial concentrations.
Although the results of this study are very promising, there is considerable room to improve CSA technology to achieve even shorter time to positivity of blood cultures. For example, the set of colorimetric indicators can be tuned to maximize the sensitivity to the volatiles released by sepsis-causing bacteria, and the growth medium can be optimized so that bacterial VOC production during growth includes the classes of volatiles to which the CSAs are most sensitive. Importantly, the BacT/ Alert bottles used in this study contain activated charcoal to absorb antibiotics, but charcoal is also well known to absorb VOCs. This may have limited the ability of our sensor to detect low concentrations of VOCs at the early stage of the bacterial growth cycle. Replacing activated charcoal with polymer beads that are more selective for antibiotics (31) might enhance CSA sensitivity and result in even faster detection and characterization of BSI.
In conclusion, the analysis of volatile metabolic biomarkers in the headspace of blood culture bottles using the CSA allowed for faster detection and the simultaneous identification of sepsis-causing bacteria, and with great accuracy. This technology also demonstrated the ability to discriminate between bacterial strains. Altogether, the CSA holds promise for shortening the time to diagnosis of sepsis, thereby improving clinical outcomes.
